Economic Valuation of Anti-retroviral Drugs in Ethiopia: Application of CVM
No Thumbnail Available
Date
2003-06
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Addis Ababa University
Abstract
In this study, the willingness to pay of people living with HIV/AIDS for antiretroviral
drugs is assessed. A contingent valuation survey was carried out on
440 adults living with HIV/AIDS. The research result indicates that the mean
willingness to pay for the drugs is Birr 163.6 and the median is Birr 100, per
month. A multivariate statistical analysis of the determinants of individual’s
willingness to pay reveals that individuals with larger family size, with others
paying for their treatment cost other than themselves and with spouse
deceased are less willing to pay for the drugs. Individuals with higher income
are more willing to pay. Older respondents are also willing to pay more.
Among the explanatory variables, income was found to be highly significant
in influencing WTP by the different estimation techniques employed in the
research implying low income levels of respondents prevent them from
acquiring the drugs, if the drugs be marketed. This calls for the participation of
many stakeholders in the acquisition and distribution of anti-retroviral drugs if
equityisdesired.
Key words: Contingent valuation method, Willingness to pay, antiretroviral
drugs, CLAD
Description
Keywords
Contingent valuation method, Willingness to pay, antiretroviral drugs, CLAD